These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 17263254)
21. Therapy-refractory schizophrenia in a patient who previously suffered from Meige's syndrome. Uemura T; Mochida M; Matsumi T; Yoshimoto K; Tatebayashi Y Neuropsychopharmacol Rep; 2019 Dec; 39(4):297-300. PubMed ID: 31743613 [TBL] [Abstract][Full Text] [Related]
22. [Dystonia as the cause of pharyngolaryngeal motility disorders]. Zwirner P; Dressler D HNO; 1995 Aug; 43(8):498-501. PubMed ID: 7558908 [TBL] [Abstract][Full Text] [Related]
23. Complete remission of neuroleptic-induced Meige's syndrome by botulinum toxin treatment: a case report. Kurata K; Kuze S; Shibata R; Hatakeyama N; Masuda A; Ito Y; Kurachi M Jpn J Psychiatry Neurol; 1993 Mar; 47(1):115-9. PubMed ID: 8105127 [TBL] [Abstract][Full Text] [Related]
30. Botulinum toxin injections for the treatment of spasmodic dysphonia. Watts CC; Whurr R; Nye C Cochrane Database Syst Rev; 2004; 2004(3):CD004327. PubMed ID: 15266530 [TBL] [Abstract][Full Text] [Related]
31. Tongue protrusion dystonia: treatment with botulinum toxin. Charles PD; Davis TL; Shannon KM; Hook MA; Warner JS South Med J; 1997 May; 90(5):522-5. PubMed ID: 9160072 [TBL] [Abstract][Full Text] [Related]
32. Risk factors and demographics in patients with spasmodic dysphonia. Schweinfurth JM; Billante M; Courey MS Laryngoscope; 2002 Feb; 112(2):220-3. PubMed ID: 11889373 [TBL] [Abstract][Full Text] [Related]
33. Botulinum A toxin for cranial-cervical dystonia: a double-blind, placebo-controlled study. Jankovic J; Orman J Neurology; 1987 Apr; 37(4):616-23. PubMed ID: 3561773 [TBL] [Abstract][Full Text] [Related]
34. Meige's syndrome in dementia with Lewy bodies. Tabet N; Sivaloganathan S J R Soc Med; 2002 Apr; 95(4):201-2. PubMed ID: 11934913 [No Abstract] [Full Text] [Related]
35. [Clinical features and factors related to the functional prognosis in Meige's syndrome]. Kamitsukasa I; Yamada T; Tokumaru Y; Hirayama K Rinsho Shinkeigaku; 1995 Mar; 35(3):231-6. PubMed ID: 7614742 [TBL] [Abstract][Full Text] [Related]
36. Botulinum toxin treatment in clinical neurology. Van den Bergh P Acta Neurol Belg; 1995; 95(2):70-9. PubMed ID: 7618431 [No Abstract] [Full Text] [Related]
37. Impact on quality of life of botulinum toxin treatments for spasmodic dysphonia and oromandibular dystonia. Bhattacharyya N; Tarsy D Arch Otolaryngol Head Neck Surg; 2001 Apr; 127(4):389-92. PubMed ID: 11296046 [TBL] [Abstract][Full Text] [Related]
39. Voice disorders in the workplace: productivity in spasmodic dysphonia and the impact of botulinum toxin. Meyer TK; Hu A; Hillel AD Laryngoscope; 2013 Nov; 123 Suppl 6():S1-14. PubMed ID: 23818277 [TBL] [Abstract][Full Text] [Related]